Contribution of Glycation and Oxidative Stress to Thyroid Gland Pathology—A Pilot Study
Authors:
- Aleksandra KuzanAleksandra Kuzan
- Emilia KrólewiczEKEmilia Królewicz
- Karolina NowakowskaKNKarolina Nowakowska
- Kamilla StachKSKamilla Stach
- Krzysztof KaliszewskiKrzysztof Kaliszewski
- Paweł DomosławskiPDPaweł Domosławski
- Łukasz KotyraŁKŁukasz Kotyra
- Andrzej GamianAGAndrzej Gamian
- Irena Kustrzeba-WójcickaIKIrena Kustrzeba-Wójcicka
Open Access
- 10 April 2021
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 11 (4) , 557
Abstract
The patho-mechanism of changes in the thyroid gland, including carcinogenesis, is a complex process, which involves oxidative stress. The goal of our investigation was to verify the extent of stress in the thyroid gland related to glycation. The study samples were comprised of blood sera, thyroid, and adipose tissue sections probed from 37 patients diagnosed with thyroid cancers and goiter. Using immuno-enzymatic and fluorometric assays we analyzed the content of advanced glycation end-products (AGEs), pentosidine, receptors for advanced glycation end-products (RAGE), scavenger receptor class (SR)-A, SR-B, glutathione, malondialdehyde and nitric oxide synthase. In addition to classic AGEs, a recent study detected the melibiose-derived glycation (MAGE) product. We demonstrated the presence of AGEs, MAGE and their receptors of the RAGE and SR-A. In addition, in the control samples of thyroid glands SR-B groups were detected as well as of pathological groups without noticeable tendency to antigen concentration in the area of carcinogenesis. Fluorescent AGEs correlate positively with glutathione, which supports the assumption that glycation stress leads to augmentation of oxidative stress and increase of the intensity of antioxidant mechanisms.Keywords
This publication has 36 references indexed in Scilit:
- Dosage de l’HbA1c et des produits d’Amadori en biologie humaineAnnales Pharmaceutiques Françaises, 2014
- Thyroid NodulesMedical Clinics of North America, 2012
- Total oxidant/antioxidant status in sera of patients with thyroid cancersEndocrine-Related Cancer, 2011
- Correlation between Oxidative Stress and Thyroid Function in Patients with Nephrotic SyndromeInternational Journal of Nephrology, 2011
- Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinomaClinical Biochemistry, 2010
- Plasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular DegenerationMolecular & Cellular Proteomics, 2009
- Oxidant/antioxidant balance in patients with thyroid cancerActa Cirurgica Brasileira, 2008
- Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin‐1 and angiogenic factors in human papillary thyroid carcinomaClinical Endocrinology, 2006
- Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescentsJournal of Endocrinological Investigation, 2002
- Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to ageAtherosclerosis, 1996